MedTrace Logo

Effect of B.Lactis Consumption on Gastro-Intestinal (GI) Symptoms in Healthy Women Reporting Minor GI Symptoms

NCT05416151 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 486

Last updated 2024-08-09

No results posted yet for this study

Summary

The purpose of this study is to assess the effect of a 28-day B.lactis consumption twice daily on Gastro-Intestinal (GI) symptoms in healthy women reporting minor GI symptoms.

Conditions

  • Gastro-intestinal Symptoms in Healthy Subjects

Interventions

OTHER

Freeze-dried biotic

2 sticks of 3g consumed daily for 28 days

OTHER

Maltodextrin

2 sticks of 3g consumed daily for 28 days

Sponsors & Collaborators

  • Euraxi Pharma

    collaborator INDUSTRY

  • Danone Global Research & Innovation Center

    lead INDUSTRY

Principal Investigators

  • Rim HASSOUNA, PhD · Danone Research, Palaiseau, France

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-05-24
Primary Completion
2023-12-15
Completion
2024-04-18

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05416151 on ClinicalTrials.gov